Last checked at 7 Jan 2011 16:12
Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons
I give below details of changes in the interests of Directors, Persons Discharging Managerial Responsibility or Connected Persons in the Ordinary shares of GlaxoSmithKline plc in respect of the under-mentioned persons arising from the purchase of Ordinary shares at a price of £12.50 per Ordinary share on 6 January 2011 through the Company's Share Reward Plan ("the Plan").
Mr A P Witty | Acquisition of 29 Ordinary shares under the Dividend Reinvestment element of the Plan
|
Mr J S Heslop | Acquisition of 29 Ordinary shares under the Dividend Reinvestment element of the Plan
|
Mr S M Bicknell | Acquisition of 29 Ordinary shares under the Dividend Reinvestment element of the Plan
|
Mr E J Gray | Acquisition of 29 Ordinary shares under the Dividend Reinvestment element of the Plan
|
Mr S A Hussain | Acquisition of 7 Ordinary shares under the Dividend Reinvestment element of the Plan
|
Dr D Pulman | Acquisition of 11 Ordinary shares under the Dividend Reinvestment element of the Plan
|
Mr D S Redfern | Acquisition of 29 Ordinary shares under the Dividend Reinvestment element of the Plan
|
Ms C Thomas | Acquisition of 29 Ordinary shares under the Dividend Reinvestment element of the Plan
|
Mr P J T Vallance | Acquisition of 13 Ordinary shares under the Dividend Reinvestment element of the Plan
|
The Company and the above-mentioned persons were advised of this information on 7 January 2011.
This notification relates to a transaction notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a).
V A Whyte
Company Secretary
7 January 2011